194 related articles for article (PubMed ID: 10873620)
1. Losartan inhibits cellular uptake of oxidized LDL by monocyte-macrophages from hypercholesterolemic patients.
Hayek T; Aviram M; Heinrich R; Sakhnini E; Keidar S
Biochem Biophys Res Commun; 2000 Jul; 273(2):417-20. PubMed ID: 10873620
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II injection into mice increases the uptake of oxidized LDL by their macrophages via a proteoglycan-mediated pathway.
Keidar S; Attias J
Biochem Biophys Res Commun; 1997 Oct; 239(1):63-7. PubMed ID: 9345270
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II administration to atherosclerotic mice increases macrophage uptake of oxidized ldl: a possible role for interleukin-6.
Keidar S; Heinrich R; Kaplan M; Hayek T; Aviram M
Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1464-9. PubMed ID: 11557673
[TBL] [Abstract][Full Text] [Related]
4. Pomegranate juice inhibits oxidized LDL uptake and cholesterol biosynthesis in macrophages.
Fuhrman B; Volkova N; Aviram M
J Nutr Biochem; 2005 Sep; 16(9):570-6. PubMed ID: 16115546
[TBL] [Abstract][Full Text] [Related]
5. Atorvastatin therapy in hypercholesterolemic patients suppresses cellular uptake of oxidized-LDL by differentiating monocytes.
Fuhrman B; Koren L; Volkova N; Keidar S; Hayek T; Aviram M
Atherosclerosis; 2002 Sep; 164(1):179-85. PubMed ID: 12119208
[TBL] [Abstract][Full Text] [Related]
6. Serotonin increases macrophage uptake of oxidized low density lipoprotein.
Aviram M; Fuhrman B; Maor I; Brook GJ
Eur J Clin Chem Clin Biochem; 1992 Feb; 30(2):55-61. PubMed ID: 1581411
[TBL] [Abstract][Full Text] [Related]
7. Pioglitazone inhibits LOX-1 expression in human coronary artery endothelial cells by reducing intracellular superoxide radical generation.
Mehta JL; Hu B; Chen J; Li D
Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):2203-8. PubMed ID: 12958047
[TBL] [Abstract][Full Text] [Related]
8. Effects of lycopene on the induction of foam cell formation by modified LDL.
Napolitano M; De Pascale C; Wheeler-Jones C; Botham KM; Bravo E
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1820-7. PubMed ID: 17911344
[TBL] [Abstract][Full Text] [Related]
9. Intraperitoneal injection of platelet secretory products into mice increases macrophage uptake of oxidized low density lipoprotein.
Hussein O; Brook GJ; Aviram M
Isr J Med Sci; 1993 Aug; 29(8):453-9. PubMed ID: 8407271
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of LOX-1 expression in aorta of hypercholesterolemic rabbits: modulation by losartan.
Chen H; Li D; Sawamura T; Inoue K; Mehta JL
Biochem Biophys Res Commun; 2000 Oct; 276(3):1100-4. PubMed ID: 11027596
[TBL] [Abstract][Full Text] [Related]
11. Sterol regulatory element binding proteins downregulate LDL receptor-related protein (LRP1) expression and LRP1-mediated aggregated LDL uptake by human macrophages.
Llorente-Cortés V; Royo T; Otero-Viñas M; Berrozpe M; Badimon L
Cardiovasc Res; 2007 Jun; 74(3):526-36. PubMed ID: 17376415
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II atherogenicity in apolipoprotein E deficient mice is associated with increased cellular cholesterol biosynthesis.
Keidar S; Attias J; Heinrich R; Coleman R; Aviram M
Atherosclerosis; 1999 Oct; 146(2):249-57. PubMed ID: 10532681
[TBL] [Abstract][Full Text] [Related]
13. The angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice.
Keidar S; Attias J; Smith J; Breslow JL; Hayek T
Biochem Biophys Res Commun; 1997 Jul; 236(3):622-5. PubMed ID: 9245700
[TBL] [Abstract][Full Text] [Related]
14. LDL-platelet interaction under oxidative stress induces macrophage foam cell formation.
Aviram M
Thromb Haemost; 1995 Jul; 74(1):560-4. PubMed ID: 8578524
[TBL] [Abstract][Full Text] [Related]
15. Atherosclerosis development in SLE patients is not determined by monocytes ability to bind/endocytose Ox-LDL.
Yassin LM; Londoño J; Montoya G; De Sanctis JB; Rojas M; Ramírez LA; García LF; Vásquez G
Autoimmunity; 2011 May; 44(3):201-10. PubMed ID: 21231894
[TBL] [Abstract][Full Text] [Related]
16. Decreased macrophage paraoxonase 2 expression in patients with hypercholesterolemia is the result of their increased cellular cholesterol content: effect of atorvastatin therapy.
Rosenblat M; Hayek T; Hussein K; Aviram M
Arterioscler Thromb Vasc Biol; 2004 Jan; 24(1):175-80. PubMed ID: 14592851
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II upregulates LDL receptor-related protein (LRP1) expression in the vascular wall: a new pro-atherogenic mechanism of hypertension.
Sendra J; Llorente-Cortés V; Costales P; Huesca-Gómez C; Badimon L
Cardiovasc Res; 2008 Jun; 78(3):581-9. PubMed ID: 18281370
[TBL] [Abstract][Full Text] [Related]
18. Ceramides reduce CD36 cell surface expression and oxidised LDL uptake by monocytes and macrophages.
Luan Y; Griffiths HR
Arch Biochem Biophys; 2006 Jun; 450(1):89-99. PubMed ID: 16620763
[TBL] [Abstract][Full Text] [Related]
19. Cholesteryl ester hydroperoxides increase macrophage CD36 gene expression via PPARalpha.
Jedidi I; Couturier M; Thérond P; Gardès-Albert M; Legrand A; Barouki R; Bonnefont-Rousselot D; Aggerbeck M
Biochem Biophys Res Commun; 2006 Dec; 351(3):733-8. PubMed ID: 17084382
[TBL] [Abstract][Full Text] [Related]
20. Differences in LDL receptor-mediated metabolism of three low density lipoprotein subfractions by human monocyte-derived macrophages: impact on the risk for atherosclerosis.
de Graaf J; Hendriks JC; Swinkels DW; Demacker PN; Stalenhoef AF
Artery; 1993; 20(4):201-30. PubMed ID: 8250739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
